Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.87
SZYM's Cash to Debt is ranked higher than
57% of the 975 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.59 vs. SZYM: 0.87 )
Ranked among companies with meaningful Cash to Debt only.
SZYM' s 10-Year Cash to Debt Range
Min: 0.87  Med: 11.13 Max: N/A
Current: 0.87
Equity to Asset 0.18
SZYM's Equity to Asset is ranked lower than
93% of the 836 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.53 vs. SZYM: 0.18 )
Ranked among companies with meaningful Equity to Asset only.
SZYM' s 10-Year Equity to Asset Range
Min: -0.63  Med: 0.53 Max: 0.89
Current: 0.18
-0.63
0.89
F-Score: 3
Z-Score: -2.58
M-Score: -3.37
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -213.76
SZYM's Operating margin (%) is ranked lower than
97% of the 962 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.14 vs. SZYM: -213.76 )
Ranked among companies with meaningful Operating margin (%) only.
SZYM' s 10-Year Operating margin (%) Range
Min: -241.86  Med: -169.11 Max: -36.03
Current: -213.76
-241.86
-36.03
Net-margin (%) -267.51
SZYM's Net-margin (%) is ranked lower than
97% of the 962 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.59 vs. SZYM: -267.51 )
Ranked among companies with meaningful Net-margin (%) only.
SZYM' s 10-Year Net-margin (%) Range
Min: -292.8  Med: -168.85 Max: -42.88
Current: -267.51
-292.8
-42.88
ROE (%) -146.96
SZYM's ROE (%) is ranked lower than
98% of the 950 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.91 vs. SZYM: -146.96 )
Ranked among companies with meaningful ROE (%) only.
SZYM' s 10-Year ROE (%) Range
Min: -143.92  Med: -64.41 Max: -39.23
Current: -146.96
-143.92
-39.23
ROA (%) -51.15
SZYM's ROA (%) is ranked lower than
97% of the 982 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.45 vs. SZYM: -51.15 )
Ranked among companies with meaningful ROA (%) only.
SZYM' s 10-Year ROA (%) Range
Min: -56.76  Med: -33.10 Max: -23.96
Current: -51.15
-56.76
-23.96
ROC (Joel Greenblatt) (%) -354.12
SZYM's ROC (Joel Greenblatt) (%) is ranked lower than
98% of the 977 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.62 vs. SZYM: -354.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SZYM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -563.92  Med: -336.25 Max: -283.7
Current: -354.12
-563.92
-283.7
Revenue Growth (3Y)(%) -6.50
SZYM's Revenue Growth (3Y)(%) is ranked lower than
82% of the 777 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.60 vs. SZYM: -6.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SZYM' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: -42.70 Max: -6.5
Current: -6.5
EBITDA Growth (3Y)(%) 13.40
SZYM's EBITDA Growth (3Y)(%) is ranked higher than
74% of the 686 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. SZYM: 13.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SZYM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: 7.10 Max: 13.4
Current: 13.4
0
13.4
EPS Growth (3Y)(%) 16.60
SZYM's EPS Growth (3Y)(%) is ranked higher than
72% of the 616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.10 vs. SZYM: 16.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SZYM' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: 8.40 Max: 16.6
Current: 16.6
0
16.6
» SZYM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

SZYM Guru Trades in Q2 2014

Chuck Royce 617,165 sh (+75.86%)
John Burbank 6,432,127 sh (+16.41%)
PRIMECAP Management 9,118,409 sh (+11.46%)
Steven Cohen 1,381,609 sh (unchged)
Paul Tudor Jones Sold Out
» More
Q3 2014

SZYM Guru Trades in Q3 2014

Paul Singer 10,000 sh (New)
Chuck Royce 884,165 sh (+43.26%)
John Burbank 8,088,672 sh (+25.75%)
Steven Cohen 1,707,846 sh (+23.61%)
John Burbank 7,103,823 sh (+10.44%)
PRIMECAP Management 9,746,809 sh (+6.89%)
John Burbank 8,088,672 sh (unchged)
» More
Q4 2014

SZYM Guru Trades in Q4 2014

Chase Coleman 500,000 sh (New)
Paul Tudor Jones 41,702 sh (New)
John Burbank 7,311,967 sh (+24.51%)
PRIMECAP Management 11,892,709 sh (+22.02%)
Paul Singer Sold Out
Steven Cohen Sold Out
John Burbank 5,872,573 sh (-17.33%)
Chuck Royce 196,718 sh (-77.75%)
» More
Q1 2015

SZYM Guru Trades in Q1 2015

John Burbank 5,872,573 sh (unchged)
Paul Tudor Jones Sold Out
Chase Coleman Sold Out
Chuck Royce Sold Out
PRIMECAP Management 11,891,709 sh (-0.01%)
» More
» Details

Insider Trades

Latest Guru Trades with SZYM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 4.79
SZYM's P/B is ranked lower than
81% of the 951 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.73 vs. SZYM: 4.79 )
Ranked among companies with meaningful P/B only.
SZYM' s 10-Year P/B Range
Min: 1.42  Med: 3.80 Max: 8.7
Current: 4.79
1.42
8.7
P/S 3.92
SZYM's P/S is ranked lower than
83% of the 1010 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.09 vs. SZYM: 3.92 )
Ranked among companies with meaningful P/S only.
SZYM' s 10-Year P/S Range
Min: 2.8  Med: 12.15 Max: 22.14
Current: 3.92
2.8
22.14
EV-to-EBIT -2.10
SZYM's EV-to-EBIT is ranked lower than
157% of the 766 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.87 vs. SZYM: -2.10 )
Ranked among companies with meaningful EV-to-EBIT only.
SZYM' s 10-Year EV-to-EBIT Range
Min: -19.1  Med: -6.60 Max: -1
Current: -2.1
-19.1
-1
Current Ratio 10.65
SZYM's Current Ratio is ranked higher than
98% of the 847 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.72 vs. SZYM: 10.65 )
Ranked among companies with meaningful Current Ratio only.
SZYM' s 10-Year Current Ratio Range
Min: 5.93  Med: 9.85 Max: 17.51
Current: 10.65
5.93
17.51
Quick Ratio 9.84
SZYM's Quick Ratio is ranked higher than
98% of the 847 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.16 vs. SZYM: 9.84 )
Ranked among companies with meaningful Quick Ratio only.
SZYM' s 10-Year Quick Ratio Range
Min: 5.93  Med: 9.48 Max: 17.36
Current: 9.84
5.93
17.36
Days Inventory 238.62
SZYM's Days Inventory is ranked lower than
96% of the 941 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 66.25 vs. SZYM: 238.62 )
Ranked among companies with meaningful Days Inventory only.
SZYM' s 10-Year Days Inventory Range
Min: 222.86  Med: 290.13 Max: 478.07
Current: 238.62
222.86
478.07
Days Sales Outstanding 25.69
SZYM's Days Sales Outstanding is ranked higher than
86% of the 806 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 58.90 vs. SZYM: 25.69 )
Ranked among companies with meaningful Days Sales Outstanding only.
SZYM' s 10-Year Days Sales Outstanding Range
Min: 6.44  Med: 32.77 Max: 141.28
Current: 25.69
6.44
141.28

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.79
SZYM's Price/Tangible Book is ranked lower than
79% of the 914 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.83 vs. SZYM: 4.79 )
Ranked among companies with meaningful Price/Tangible Book only.
SZYM' s 10-Year Price/Tangible Book Range
Min: 2.27  Med: 4.14 Max: 7.21
Current: 4.79
2.27
7.21
Price/Median PS Value 0.32
SZYM's Price/Median PS Value is ranked higher than
97% of the 920 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.26 vs. SZYM: 0.32 )
Ranked among companies with meaningful Price/Median PS Value only.
SZYM' s 10-Year Price/Median PS Value Range
Min: 0.27  Med: 1.09 Max: 1.69
Current: 0.32
0.27
1.69
Earnings Yield (Greenblatt) (%) -54.55
SZYM's Earnings Yield (Greenblatt) (%) is ranked lower than
98% of the 977 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.40 vs. SZYM: -54.55 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SZYM' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -99.8  Med: 0.00 Max: 0
Current: -54.55
-99.8
0

Business Description

Industry: Chemicals » Specialty Chemicals
Compare: » details
Traded in other countries:S7Y.Germany,
Solazyme Inc was incorporated in the State of Delaware on March 31, 2003. The Company, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. The Company focuses on selling oil-based products, including tailored oils and powdered oils, to companies that use them as intermediates and ingredients. The Company has also invested in a consumer-focused business that commercializes branded products manufactured through its various proprietary processes. Its tailored oils offer additional value as compared to conventional oils. The Company's renewable oil addresses the market needs of fuel, chemicals, nutritionals, and skin and personal care. Its competitors include: DSM Food Specialties and DuPont Nutrition & Health. Its nutrition products are subject to regulation by various government agencies, including the U.S. Food and Drug Administration, state and local agencies and similar agencies outside the United States.
» More Articles for SZYM

Headlines

Articles On GuruFocus.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Solazyme, Inc. of Pendency of Clas Jul 01 2015 
chfc Jun 16 2015 
chfc Jun 16 2015 
John Burbank's Top Five Increases of the First Quarter May 29 2013 
A New Beginning for Codexis? Mar 08 2013 
comment on SZYM Feb 23 2013 
comment on SZYM Feb 23 2013 
comment on SZYM Feb 23 2013 
comment on SZYM Feb 23 2013 
comment on SZYM Feb 23 2013 

More From Other Websites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Solazyme, Inc. of Pendency of... Jul 01 2015
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Solazyme, Inc. Jun 30 2015
Solazyme Bunge Renewable Oils Completes Key Redundant Power and Steam Supplies Jun 30 2015
Solazyme Bunge Renewable Oils Completes Key Redundant Power and Steam Supplies Jun 30 2015
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Jun 29 2015
Lifshitz & Miller Law Firm Announces Investigation of Home Properties, Inc., Keurig Green Mountain,... Jun 29 2015
Volkswagen Completes Successful Renewable Fuel Evaluation With Solazyme and Amyris Jun 29 2015
SECURITIES FRAUD ALERT: The Law Firm of Andrews & Springer LLC Announces That A Securities Fraud... Jun 29 2015
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Ongoing Investigation of Claims against... Jun 29 2015
SOLAZYME SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... Jun 26 2015
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Solazyme, Inc. Jun 26 2015
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Solazyme, Inc. --... Jun 26 2015
SOLAZYME ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000... Jun 26 2015
Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Solazyme,... Jun 26 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Solazyme, Inc.... Jun 25 2015
LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action... Jun 25 2015
Robbins Arroyo LLP: Solazyme, Inc. (SZYM) Misled Shareholders According to a Recently Filed Class... Jun 25 2015
Harwood Feffer LLP Announces Investigation of Solzyme, Inc. Jun 25 2015
EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against... Jun 25 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Solazyme, Inc. of Pendency of... Jun 25 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK